Reportlinker Adds Epidemiology: Epilepsy
Apr 26, 2011, 06:02 ET
NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0484937/Epidemiology-Epilepsy.html
Datamonitor has estimated that there were approximately 4.5 million cases of diagnosed active epilepsy in 2010 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Almost half of this patient population lives in the US. Datamonitor expects prevalence rates to remain constant over the forecast period (2010–20). As such, the aging populations in thGain insight to market potential, including a robust 10-year epidemiology forecast of prevalent cases of diagnosed active epilepsy. Understand the key epidemiologic risk factors associated with epilepsy. Datamonitor expects an increase in diagnosed active epilepsy cases in the next decade in the seven major markets as a result of an increase in populations. Chronic epilepsy can result in brain damage, disability, and a low quality of life causing high social and economic burden What are the most robust epidemiologic studies for diagnosed active epilepsy prevalence data? How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?How do changes in population structure and risk factors affect the trend in prevalent diagnosed active epilepsy cases?
Executive Summary
Key findings
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Disease definition
GLOBAL VARIATION AND HISTORICAL TRENDS
Epilepsy prevalence is comparable in the seven major markets, yet different than in the developing world
Prevalence: higher in children and in those with low socioeconomic status
Incidence: decreasing in children while increasing in elderly
Mortality: highest in children
CO-MORBIDITIES
Depression is the common co-morbidity
RISK FACTORS
Idiopathic and cryptogenic are dominant risk factors of epilepsy
Cerebrovascular disease: most common identifiable cause in adults
Head injury: severity dependent
Central nervous system infection and tumors: cysticercosis is the most common
Perinatal factors: most prevalent in developing countries
Other factors: family history and alcohol
EPIDEMIOLOGIC FORECASTING OF EPILEPSY
Overview
US
Sources used
Methods
Japan
Sources used
Methods
France
Sources used
Methods
Germany
Sources used
Italy
Sources used
Methods
Spain
Sources used
Methods
UK
Sources used
Methods
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends
DISCUSSION
Strengths and limitations of our epidemiologic projections
Conclusions
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX A
Report methodology
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker